Ledger.Open graph →
SEC Form D · filed April 2, 2024

TFF Pharmaceuticals, Inc

Offering
$1.2M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
FORT WORTH, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Stephen S. Rocamboli · AUSTIN, TXDirectorCatherine S. Lee · SAN DIEGO, CADirectorBrandi S. Roberts · FORT WORTH, TXDirectorThomas S. King · FORT WORTH, TXDirectorRobert S. Mills, Jr · Austin, TXDirectorHarlan S. Weisman · FORT WORTH, TXExec · DirectorZamaneh S. Mikhak · FORT WORTH, TXExecKirk S. Coleman · Austin, TXExecMichael S. Patane · FORT WORTH, TXDirectorBrandi S. Roberts · FORT WORTH, TXDirectorThomas S. King · FORT WORTH, TXDirectorRobert S. Mills, Jr · Austin, TXDirectorStephen S. Rocamboli · FORT WORTH, TXDirectorHarlan S. Weisman · AUSTIN, TXExec · DirectorZamaneh S. Mikhak · FORT WORTH, TXExecKirk S. Coleman · Austin, TXExecMichael S. Patane · FORT WORTH, TXDirectorCatherine S. Lee · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗